会员体验
专利管家(专利管理)
工作空间(专利管理)
风险监控(情报监控)
数据分析(专利分析)
侵权分析(诉讼无效)
联系我们
交流群
官方交流:
QQ群: 891211   
微信请扫码    >>>
现在联系顾问~
热词
    • 2. 发明授权
    • Molecular lymphatic mapping of sentinel lymph nodes
    • 前哨淋巴结的分子淋巴图
    • US07897336B2
    • 2011-03-01
    • US10641595
    • 2003-08-15
    • Dave S. B. HoonBret Taback
    • Dave S. B. HoonBret Taback
    • C12P19/34C07H21/04
    • A61K49/006C12Q1/6886C12Q2600/112
    • The present invention describes a method for identification and labeling of sentinel lymph nodes (SLNs) and the presence or absence of lymph node metastases as an important diagnostic and prognostic factor in early stage cancers of all types. The method, know as Molecular Lymphatic Mapping, uses traditional dye/radioactive tracer based techniques in conjunction with a nucleic acid marker to identify and label the SLN, not only for current diagnostic methods, but for archival purposes. In addition, MLM can be used to deliver a therapeutic gene or genes to the SLN to activate tumor immunity to tumor cells, and/or to inhibit tumor metastases. The methods may be combined with therapeutic intervention including chemotherapy and radiotherapy.
    • 本发明描述了前哨淋巴结(SLN)的鉴定和标记方法以及淋巴结转移的存在或不存在,作为所有类型早期癌症的重要诊断和预后因素。 该方法称为分子淋巴图,使用传统的基于染料/放射性示踪剂的技术与核酸标记物结合来鉴定和标记SLN,不仅用于当前的诊断方法,而且用于归档目的。 此外,MLM可用于将治疗基因或基因递送至SLN,以激活对肿瘤细胞的肿瘤免疫,和/或抑制肿瘤转移。 这些方法可以与包括化学疗法和放射治疗在内的治疗干预相结合。